Prime Medicine (PRME) Change in Acquisitions & Divestments (2021 - 2026)

Prime Medicine (PRME) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $50.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 1596.27% year-over-year to $50.9 million; the trailing twelve-month figure through Mar 2026 stood at $143.7 million (up 6.66% YoY), and the FY2025 full-year result was $95.8 million, down 53.09% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $50.9 million, up from $39.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $72.5 million in Q1 2024 and bottomed at $3.0 million in Q1 2025.
• The 5-year median for Change in Acquisitions & Divestments is $32.9 million (2024), against an average of $33.9 million.
• The widest annual swing landed in 2025, when Change in Acquisitions & Divestments sank 95.86%; it then jumped 1596.27% in 2026.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $25.0 million in 2022, then soared by 90.14% to $47.5 million in 2023, then slumped by 30.79% to $32.9 million in 2024, then advanced by 18.84% to $39.1 million in 2025, then soared by 30.15% to $50.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $50.9 million (Q1 2026), $39.1 million (Q4 2025), and $42.4 million (Q3 2025), per Business Quant data.

Peer Comparison